New standards in hypertension and cardiovascular risk management: focus on telmisartan

Item

http://www.wikidata.org/entity/Q37744529

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New standards in hypertension and cardiovascular risk management: focus on telmisartan

@en

New standards in hypertension and cardiovascular risk management: focus on telmisartan.

@nl

type

Item

label

New standards in hypertension and cardiovascular risk management: focus on telmisartan

@en

New standards in hypertension and cardiovascular risk management: focus on telmisartan.

@nl

prefLabel

New standards in hypertension and cardiovascular risk management: focus on telmisartan

@en

New standards in hypertension and cardiovascular risk management: focus on telmisartan.

@nl

P1476

New standards in hypertension and cardiovascular risk management: focus on telmisartan

@en

P2093

Antonio Galzerano

http://www.w3.org/2001/XMLSchema#string

Carlo Gaudio

http://www.w3.org/2001/XMLSchema#string

Cristina Capogrosso

http://www.w3.org/2001/XMLSchema#string

Diana Lama

http://www.w3.org/2001/XMLSchema#string

Domenico Galzerano

http://www.w3.org/2001/XMLSchema#string

Paola Paparello

http://www.w3.org/2001/XMLSchema#string

Sara Di Michele

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patient

Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs

Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.

P304

113-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/VHRM.S7857

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20448797

http://www.w3.org/2001/XMLSchema#string

P921

carboxylic acid

mechanism of action

arterial hypertension

hydrocarbon

P932

2860444

http://www.w3.org/2001/XMLSchema#string